Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

1.16
Delayed Data
As of 3:54pm ET
 -0.02 / -1.69%
Today’s Change
0.80
Today|||52-Week Range
3.53
-22.15%
Year-to-Date
No recent news for Alexza Pharmaceuticals Inc.

Today’s Trading

Previous close1.18
Today’s open1.12
Day’s range1.12 - 1.25
Volume37,940
Average volume (3 months)43,638
Market cap$22.9M
Dividend yield--
Data as of 3:54pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+13.03%
Earnings growth (this year)+38.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-88.38%
P/E ratioNM
Price/Sales4.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JAGXJaguar Animal Health...+0.53+18.47%
OPXAOpexa Therapeutics I...+0.03+7.53%
CLRBCellectar Bioscience...-0.08-2.54%
PRPHProPhase Labs Inc+0.07+4.61%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$5.6M
Annual profit (last year)-$36.7M
Net profit margin-660.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Thomas Braxton King
CFO, Secretary &
Senior VP-Finance
Mark K. Oki
Corporate headquarters
Mountain View, California

Forecasts

Partner Offers